These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29735719)

  • 1. Reduction of Cellular Nucleic Acid Binding Protein Encoded by a Myotonic Dystrophy Type 2 Gene Causes Muscle Atrophy.
    Wei C; Stock L; Schneider-Gold C; Sommer C; Timchenko NA; Timchenko L
    Mol Cell Biol; 2018 Jul; 38(14):. PubMed ID: 29735719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
    Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
    Timchenko L
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational control of polyamine metabolism by CNBP is required for
    Coni S; Falconio FA; Marzullo M; Munafò M; Zuliani B; Mosti F; Fatica A; Ianniello Z; Bordone R; Macone A; Agostinelli E; Perna A; Matkovic T; Sigrist S; Silvestri G; Canettieri G; Ciapponi L
    Elife; 2021 Sep; 10():. PubMed ID: 34517941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (CCUG)
    Yenigun VB; Sirito M; Amcheslavky A; Czernuszewicz T; Colonques-Bellmunt J; García-Alcover I; Wojciechowska M; Bolduc C; Chen Z; López Castel A; Krahe R; Bergmann A
    Dis Model Mech; 2017 Aug; 10(8):993-1003. PubMed ID: 28623239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
    Meola G; Cardani R
    Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2.
    Cardani R; Giagnacovo M; Rossi G; Renna LV; Bugiardini E; Pizzamiglio C; Botta A; Meola G
    Neuromuscul Disord; 2014 Dec; 24(12):1042-53. PubMed ID: 25139674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the rate of protein translation in patients with myotonic dystrophy 2.
    Huichalaf C; Schoser B; Schneider-Gold C; Jin B; Sarkar P; Timchenko L
    J Neurosci; 2009 Jul; 29(28):9042-9. PubMed ID: 19605641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.
    Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T
    Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?
    Malatesta M
    Eur J Histochem; 2012 Aug; 56(3):e36. PubMed ID: 23027352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of protein homeostasis in myotonic dystrophies.
    Meola G; Jones K; Wei C; Timchenko LT
    Histol Histopathol; 2013 Sep; 28(9):1089-98. PubMed ID: 23536431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.
    Vihola A; Bachinski LL; Sirito M; Olufemi SE; Hajibashi S; Baggerly KA; Raheem O; Haapasalo H; Suominen T; Holmlund-Hampf J; Paetau A; Cardani R; Meola G; Kalimo H; Edström L; Krahe R; Udd B
    Acta Neuropathol; 2010 Apr; 119(4):465-79. PubMed ID: 20066428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
    Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
    Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Myotonic Dystrophy Type 2 Using
    Marzullo M; Coni S; De Simone A; Canettieri G; Ciapponi L
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2.
    Kleefeld F; Horvath R; Pinal-Fernandez I; Mammen AL; Casal-Dominguez M; Hathazi D; Melchert S; Hahn K; Sickmann A; Muselmann-Genschow C; Hentschel A; Preuße C; Roos A; Schoser B; Stenzel W
    Acta Neuropathol; 2024 Jan; 147(1):19. PubMed ID: 38240888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCUG repeats reduce the rate of global protein synthesis in myotonic dystrophy type 2.
    Schneider-Gold C; Timchenko LT
    Rev Neurosci; 2010; 21(1):19-28. PubMed ID: 20458885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy.
    Foltz SJ; Luan J; Call JA; Patel A; Peissig KB; Fortunato MJ; Beedle AM
    Skelet Muscle; 2016; 6():20. PubMed ID: 27257474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
    Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
    Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal Skeletal Muscle Regeneration plus Mild Alterations in Mature Fiber Type Specification in Fktn-Deficient Dystroglycanopathy Muscular Dystrophy Mice.
    Foltz SJ; Modi JN; Melick GA; Abousaud MI; Luan J; Fortunato MJ; Beedle AM
    PLoS One; 2016; 11(1):e0147049. PubMed ID: 26751696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.